Management of Kidney Cancer: Canadian Kidney Cancer Forum Consensus Update 2011

The overall incidence is increasing by 2% per year for unknown reasons. New targeted systemic therapies, which have been integrated into clinical practice with evolving experience, have been available for more than 5 years. Preservation of kidney func-tion with widespread adoption of partial nephrectomy is a focus of treatment of early stage disease. These and other advances have revolutionized care and stimulated research and discovery. There are several guidelines in Canada that address various aspects of patient care in RCC.